Chemical Structure (Lac07 0000 01)
Chemical structure diagram of Lacosamide, the active ingredient shown in the image.*
Lacosamide Injection
Product Images NDC 65219-204
7 FDA label images from Fresenius Kabi Usa, Llc · Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 7 technical images submitted to the FDA as part of the official labeling for Lacosamide (NDC 65219-204). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Fresenius Kabi Usa, Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure 1 (Lac07 0000 02)
A bar chart comparing the mean seizure reduction rates (%) across three studies (Study 2, Study 3, Study 4) between placebo and Lacosamide at various doses (400, 600, 800 mg). The chart illustrates higher seizure reduction percentages with Lacosamide compared to placebo in all studies and doses.*
Figure 2 (Lac07 0000 03)
A line graph depicting the responder rate (reduction of seizures) versus percent of patients for Lacosamide injection at doses of 200 mg/day, 400 mg/day, and 600 mg/day compared with placebo. The graph shows responder percentages on the vertical axis and percent of patients on the horizontal axis.*
Fresenius Kabi Logo (Lac07 0000 04)
Lacosamide injection 10 mg/mL single-dose vial, labeled for intravenous use. The label shows the brand and generic name 'Lacosamide' prominently and indicates the strength and dosage form. The labeler is Fresenius Kabi USA, LLC, and the packaging includes NDC 65219-204.*
Fresenius Kabi Logo (Lac07 0000 05)
Principal Display Panel – 20 mL Vial Label (Lac07 0000 06)
Label for Lacosamide Injection, USP 10 mg/mL, 200 mg per 20 mL single-dose vial for intravenous use. The label includes storage instructions, dosage reference, and cautions. It is manufactured by Fresenius Kabi USA, LLC, Lake Zurich, IL, with NDC 65219-204-01.*
Principal Display Panel – 20 mL Tray Label (Lac07 0000 07)
Label for Lacosamide Injection, USP 200 mg per 20 mL (10 mg per mL) intravenous injection by Fresenius Kabi USA, LLC. The label indicates a 20 mL single-dose vial with 200 mg lacosamide and packaging of 10 vials. It includes usage instructions, storage conditions, and a barcode.*
* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.
